Tapewire

Nasdaq · USD

WHWK

Whitehawk Therapeutics, Inc.

Export transactions ↓
Tapewire entity
6074
SEC CIK
0001422142
Parsed reports
260

Last 12 months

Inside the activity.

0 purchase rows · 14 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202600
Mar 202603
Apr 2026011
May 202600
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
July 05, 2023 Filed Jul 6, 2023 23:36 UTC
Desai NeilDirector · Executive Chairman
SaleCommon Stock 16,171 $6.55 $105,873.15
Disclosure

SEC source: 0001209191-23-041700 · doc4.xml · nonDerivative · entry 2

Desai Neil · CIK 0001878692 · Director · Executive Chairman

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 1,763,372

F1 · kind: The sales reported were effected pursuant to a Rule 10b5-1 trading plan originally adopted on September 20, 2021, as replaced on December 1, 2022, by the Reporting Person.

F4 · price: Represents the weighted average share price of an aggregate total of 16,171 shares sold in the price range of $6.41 to $6.715 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

F3 · ownership.nature: Shares held by Neil Prafulla Desai, Trustee of the Anishka Family Trust (the "Family Trust"). The Reporting Person is trustee of the Family Trust.

Read SEC document
July 03, 2023 Filed Jul 6, 2023 23:36 UTC
Desai NeilDirector · Executive Chairman
SaleCommon Stock 10,000 $6.64 $66,446.00
Disclosure

SEC source: 0001209191-23-041700 · doc4.xml · nonDerivative · entry 1

Desai Neil · CIK 0001878692 · Director · Executive Chairman

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 1,779,543

F1 · kind: The sales reported were effected pursuant to a Rule 10b5-1 trading plan originally adopted on September 20, 2021, as replaced on December 1, 2022, by the Reporting Person.

F2 · price: Represents the weighted average share price of an aggregate total of 10,000 shares sold in the price range of $6.53 to $6.815 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

F3 · ownership.nature: Shares held by Neil Prafulla Desai, Trustee of the Anishka Family Trust (the "Family Trust"). The Reporting Person is trustee of the Family Trust.

Read SEC document
June 15, 2023 Filed Jun 21, 2023 00:59 UTC
Aghazadeh BehzadDirector · 10% owner · See remarks
Avoro Capital Advisors LLCDirector · 10% owner · See remarks
Avoro Ventures LLCDirector · 10% owner · See remarks
GrantStock Option (right to buy) · Derivative 28,255 $0.00 Strike: $8.20 $0.00
Disclosure

SEC source: 0001209191-23-038675 · doc4.xml · derivative · entry 1

Aghazadeh Behzad · CIK 0001701815 · Director · 10% owner · See remarks

Avoro Capital Advisors LLC · CIK 0001633313 · Director · 10% owner · See remarks

Avoro Ventures LLC · CIK 0001879253 · Director · 10% owner · See remarks

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 28,255

Underlying: Common Stock · 28,255 shares

Expires 2033-06-15

F1 · derivative.exercise_date: Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through such applicable date, one hundred percent (100%) of the shares subject to the option shall vest on the earlier of (i) the one (1) year anniversary of the Date of Grant or (ii) the day immediately prior to the next annual meeting of stockholders following the Date of Grant. "Date of Grant" shall mean June 15, 2023.

F2 · ownership.direct: This Form 4 is filed by Avoro Capital Advisors LLC, a Delaware limited liability company ("Avoro Capital Advisors"), Avoro Ventures LLC, a Delaware limited liability company ("Avoro Ventures") and Behzad Aghazadeh ("Dr. Aghazadeh", and together with Avoro Capital Advisors and Avoro Ventures, the "Reporting Persons"). Dr. Aghazadeh serves as the portfolio manager and controlling person of Avoro Capital Advisors and Avoro Ventures LLC.

F3 · ownership.direct: The filing of this statement shall not be deemed an admission that any Reporting Person is the beneficial owner of the securities reported herein for purposes of Section 16 of the Securities Act of 1934, as amended, or otherwise. Each of the Reporting Persons expressly disclaims beneficial ownership of the securities reported herein except to the extent of its or his pecuniary interest therein.

Read SEC document
June 15, 2023 Filed Jun 21, 2023 00:22 UTC GrantStock Option (right to buy) · Derivative 28,255 $0.00 Strike: $8.20 $0.00
Disclosure

SEC source: 0001209191-23-038665 · doc4.xml · derivative · entry 1

Castelein Caley · CIK 0001355758 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 28,255

Underlying: Common Stock · 28,255 shares

Expires 2033-06-15

F1 · derivative.exercise_date: Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through such applicable date, one hundred percent (100%) of the shares subject to the option shall vest on the earlier of (i) the one (1) year anniversary of the Date of Grant or (ii) the day immediately prior to the next annual meeting of stockholders following the Date of Grant. "Date of Grant" shall mean June 15, 2023.

Read SEC document
June 15, 2023 Filed Jun 21, 2023 00:20 UTC GrantStock Option (right to buy) · Derivative 28,255 $0.00 Strike: $8.20 $0.00
Disclosure

SEC source: 0001209191-23-038664 · doc4.xml · derivative · entry 1

Maroun Richard E · CIK 0001364590 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 28,255

Underlying: Common Stock · 28,255 shares

Expires 2033-06-15

F1 · derivative.exercise_date: Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through such applicable date, one hundred percent (100%) of the shares subject to the option shall vest on the earlier of (i) the one (1) year anniversary of the Date of Grant or (ii) the day immediately prior to the next annual meeting of stockholders following the Date of Grant. "Date of Grant" shall mean June 15, 2023.

Read SEC document
June 15, 2023 Filed Jun 21, 2023 00:19 UTC
Reeve EmmaDirector
GrantStock Option (right to buy) · Derivative 28,255 $0.00 Strike: $8.20 $0.00
Disclosure

SEC source: 0001209191-23-038663 · doc4.xml · derivative · entry 1

Reeve Emma · CIK 0001680329 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 28,255

Underlying: Common Stock · 28,255 shares

Expires 2033-06-15

F1 · derivative.exercise_date: Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through such applicable date, one hundred percent (100%) of the shares subject to the option shall vest on the earlier of (i) the one (1) year anniversary of the Date of Grant or (ii) the day immediately prior to the next annual meeting of stockholders following the Date of Grant. "Date of Grant" shall mean June 15, 2023.

Read SEC document
June 15, 2023 Filed Jun 21, 2023 00:19 UTC
Dalal AnupamDirector
GrantStock Option (right to buy) · Derivative 28,255 $0.00 Strike: $8.20 $0.00
Disclosure

SEC source: 0001209191-23-038662 · doc4.xml · derivative · entry 1

Dalal Anupam · CIK 0001602474 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 28,255

Underlying: Common Stock · 28,255 shares

Expires 2033-06-15

F1 · derivative.exercise_date: Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through such applicable date, one hundred percent (100%) of the shares subject to the option shall vest on the earlier of (i) the one (1) year anniversary of the Date of Grant or (ii) the day immediately prior to the next annual meeting of stockholders following the Date of Grant. "Date of Grant" shall mean June 15, 2023.

Read SEC document
June 15, 2023 Filed Jun 21, 2023 00:18 UTC GrantStock Option (right to buy) · Derivative 28,255 $0.00 Strike: $8.20 $0.00
Disclosure

SEC source: 0001209191-23-038661 · doc4.xml · derivative · entry 1

Hehenberger Karin M. · CIK 0001548029 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 28,255

Underlying: Common Stock · 28,255 shares

Expires 2033-06-15

F1 · derivative.exercise_date: Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through such applicable date, one hundred percent (100%) of the shares subject to the option shall vest on the earlier of (i) the one (1) year anniversary of the Date of Grant or (ii) the day immediately prior to the next annual meeting of stockholders following the Date of Grant. "Date of Grant" shall mean June 15, 2023.

Read SEC document
June 06, 2023 Filed Jun 7, 2023 00:11 UTC
Desai NeilDirector · Executive Chairman · 10% owner
SaleCommon Stock 7,260 $8.19 $59,452.87
Disclosure

SEC source: 0001209191-23-034888 · doc4.xml · nonDerivative · entry 1

Desai Neil · CIK 0001878692 · Director · Executive Chairman · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 1,789,543

F1 · kind: The sales reported were effected pursuant to a Rule 10b5-1 trading plan originally adopted on September 20, 2021, as replaced on December 1, 2022, by the Reporting Person.

F2 · price: Represents the weighted average share price of an aggregate total of 7,260 shares sold in the price range of $8.02 to $8.34 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

F3 · ownership.nature: Shares held by Neil Prafulla Desai, Trustee of the Anishka Family Trust (the "Family Trust"). The Reporting Person is trustee of the Family Trust.

Read SEC document
June 05, 2023 Filed Jun 5, 2023 23:01 UTC
Desai NeilDirector · Executive Chairman · 10% owner
SaleCommon Stock 17,315 $8.11 $140,417.72
Disclosure

SEC source: 0001209191-23-034632 · doc4.xml · nonDerivative · entry 3

Desai Neil · CIK 0001878692 · Director · Executive Chairman · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 1,796,803

F1 · kind: The sales reported were effected pursuant to a Rule 10b5-1 trading plan originally adopted on September 20, 2021, as replaced on December 1, 2022, by the Reporting Person.

F5 · price: Represents the weighted average share price of an aggregate total of 17,315 shares sold in the price range of $7.98 to $8.19 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

F3 · ownership.nature: Shares held by Neil Prafulla Desai, Trustee of the Anishka Family Trust (the "Family Trust"). The Reporting Person is trustee of the Family Trust.

Read SEC document
June 02, 2023 Filed Jun 5, 2023 23:01 UTC
Desai NeilDirector · Executive Chairman · 10% owner
SaleCommon Stock 12,443 $7.99 $99,420.81
Disclosure

SEC source: 0001209191-23-034632 · doc4.xml · nonDerivative · entry 2

Desai Neil · CIK 0001878692 · Director · Executive Chairman · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 1,814,118

F1 · kind: The sales reported were effected pursuant to a Rule 10b5-1 trading plan originally adopted on September 20, 2021, as replaced on December 1, 2022, by the Reporting Person.

F4 · price: Represents the weighted average share price of an aggregate total of 12,443 shares sold in the price range of $7.90 to $8.07 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

F3 · ownership.nature: Shares held by Neil Prafulla Desai, Trustee of the Anishka Family Trust (the "Family Trust"). The Reporting Person is trustee of the Family Trust.

Read SEC document
June 01, 2023 Filed Jun 5, 2023 23:01 UTC
Desai NeilDirector · Executive Chairman · 10% owner
SaleCommon Stock 4,982 $7.92 $39,468.40
Disclosure

SEC source: 0001209191-23-034632 · doc4.xml · nonDerivative · entry 1

Desai Neil · CIK 0001878692 · Director · Executive Chairman · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 1,826,561

F1 · kind: The sales reported were effected pursuant to a Rule 10b5-1 trading plan originally adopted on September 20, 2021, as replaced on December 1, 2022, by the Reporting Person.

F2 · price: Represents the weighted average share price of an aggregate total of 4,982 shares sold in the price range of $7.82 to $8.05 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

F3 · ownership.nature: Shares held by Neil Prafulla Desai, Trustee of the Anishka Family Trust (the "Family Trust"). The Reporting Person is trustee of the Family Trust.

Read SEC document
May 04, 2023 Filed May 5, 2023 20:16 UTC
Desai NeilDirector · Executive Chairman · 10% owner
SaleCommon Stock 2,305 $7.57 $17,444.70
Disclosure

SEC source: 0001209191-23-027672 · doc4.xml · nonDerivative · entry 1

Desai Neil · CIK 0001878692 · Director · Executive Chairman · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 1,831,543

F1 · kind: The sales reported were effected pursuant to a Rule 10b5-1 trading plan originally adopted on September 20, 2021, as replaced on December 1, 2022, by the Reporting Person.

F2 · price: Represents the weighted average share price of an aggregate total of 2,305 shares sold in the price range of $7.47 to $7.75 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

F3 · ownership.nature: Shares held by Neil Prafulla Desai, Trustee of the Anishka Family Trust (the "Family Trust"). The Reporting Person is trustee of the Family Trust.

Read SEC document
May 03, 2023 Filed May 3, 2023 22:55 UTC
Desai NeilDirector · Executive Chairman · 10% owner
SaleCommon Stock 7,695 $7.68 $59,072.98
Disclosure

SEC source: 0001209191-23-027161 · doc4.xml · nonDerivative · entry 3

Desai Neil · CIK 0001878692 · Director · Executive Chairman · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 1,833,848

F1 · kind: The sales reported were effected pursuant to a Rule 10b5-1 trading plan originally adopted on September 20, 2021, as replaced on December 1, 2022, by the Reporting Person.

F5 · price: Represents the weighted average share price of an aggregate total of 7,695 shares sold in the price range of $7.46 to $7.83 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

F3 · ownership.nature: Shares held by Neil Prafulla Desai, Trustee of the Anishka Family Trust (the "Family Trust"). The Reporting Person is trustee of the Family Trust.

Read SEC document
May 02, 2023 Filed May 3, 2023 22:55 UTC
Desai NeilDirector · Executive Chairman · 10% owner
SaleCommon Stock 7,521 $7.48 $56,224.74
Disclosure

SEC source: 0001209191-23-027161 · doc4.xml · nonDerivative · entry 2

Desai Neil · CIK 0001878692 · Director · Executive Chairman · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 1,841,543

F1 · kind: The sales reported were effected pursuant to a Rule 10b5-1 trading plan originally adopted on September 20, 2021, as replaced on December 1, 2022, by the Reporting Person.

F4 · price: Represents the weighted average share price of an aggregate total of 7,521 shares sold in the price range of $7.37 to $7.78 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

F3 · ownership.nature: Shares held by Neil Prafulla Desai, Trustee of the Anishka Family Trust (the "Family Trust"). The Reporting Person is trustee of the Family Trust.

Read SEC document
May 01, 2023 Filed May 3, 2023 22:55 UTC
Desai NeilDirector · Executive Chairman · 10% owner
SaleCommon Stock 24,479 $7.80 $190,894.59
Disclosure

SEC source: 0001209191-23-027161 · doc4.xml · nonDerivative · entry 1

Desai Neil · CIK 0001878692 · Director · Executive Chairman · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 1,849,064

F1 · kind: The sales reported were effected pursuant to a Rule 10b5-1 trading plan originally adopted on September 20, 2021, as replaced on December 1, 2022, by the Reporting Person.

F2 · price: Represents the weighted average share price of an aggregate total of 24,479 shares sold in the price range of $7.68 to $7.855 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

F3 · ownership.nature: Shares held by Neil Prafulla Desai, Trustee of the Anishka Family Trust (the "Family Trust"). The Reporting Person is trustee of the Family Trust.

Read SEC document
April 06, 2023 Filed Apr 7, 2023 00:45 UTC
Desai NeilDirector · Executive Chairman · 10% owner
SaleCommon Stock 12,212 $7.09 $86,616.05
Disclosure

SEC source: 0001209191-23-023692 · doc4.xml · nonDerivative · entry 1

Desai Neil · CIK 0001878692 · Director · Executive Chairman · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 1,873,543

F1 · kind: The sales reported were effected pursuant to a Rule 10b5-1 trading plan originally adopted on September 20, 2021, as replaced on December 1, 2022, by the Reporting Person.

F2 · price: Represents the weighted average share price of an aggregate total of 12,212 shares sold in the price range of $7.00 to $7.23 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

F3 · ownership.nature: Shares held by Neil Prafulla Desai, Trustee of the Anishka Family Trust (the "Family Trust"). The Reporting Person is trustee of the Family Trust.

Read SEC document
April 05, 2023 Filed Apr 5, 2023 23:32 UTC
Desai NeilDirector · Executive Chairman · 10% owner
SaleCommon Stock 7,336 $7.24 $53,075.96
Disclosure

SEC source: 0001209191-23-023483 · doc4.xml · nonDerivative · entry 3

Desai Neil · CIK 0001878692 · Director · Executive Chairman · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 1,885,755

F1 · kind: The sales reported were effected pursuant to a Rule 10b5-1 trading plan originally adopted on September 20, 2021, as replaced on December 1, 2022, by the Reporting Person.

F5 · price: Represents the weighted average share price of an aggregate total of 7,336 shares sold in the price range of $7.20 to $7.37 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

F3 · ownership.nature: Shares held by Neil Prafulla Desai, Trustee of the Anishka Family Trust (the "Family Trust"). The Reporting Person is trustee of the Family Trust.

Read SEC document
April 04, 2023 Filed Apr 5, 2023 23:32 UTC
Desai NeilDirector · Executive Chairman · 10% owner
SaleCommon Stock 12,869 $7.30 $93,981.02
Disclosure

SEC source: 0001209191-23-023483 · doc4.xml · nonDerivative · entry 2

Desai Neil · CIK 0001878692 · Director · Executive Chairman · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 1,893,091

F1 · kind: The sales reported were effected pursuant to a Rule 10b5-1 trading plan originally adopted on September 20, 2021, as replaced on December 1, 2022, by the Reporting Person.

F4 · price: Represents the weighted average share price of an aggregate total of 12,869 shares sold in the price range of $7.20 to $7.40 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

F3 · ownership.nature: Shares held by Neil Prafulla Desai, Trustee of the Anishka Family Trust (the "Family Trust"). The Reporting Person is trustee of the Family Trust.

Read SEC document
April 03, 2023 Filed Apr 4, 2023 20:07 UTC
Giacobello Scott M.CFO, Interim CEO & President
GrantStock Option (right to buy) · Derivative 100,000 $0.00 Strike: $7.47 $0.00
Disclosure

SEC source: 0001209191-23-022657 · doc4.xml · derivative · entry 1

Giacobello Scott M. · CIK 0001754154 · CFO, Interim CEO & President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 100,000

Underlying: Common Stock · 100,000 shares

Expires 2033-04-03

F1 · derivative.exercise_date: Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, twenty five percent (25%) of the shares subject to the option shall vest on the one year anniversary of the Vesting Commencement Date, and one forty-eighth (1/48th) of the total shares subject to the option shall vest each month thereafter on the same day as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month) such that all shares of common stock subject to the option shall be fully vested on the four year anniversary of the Vesting Commencement Date. "Vesting Commencement Date" shall mean April 3, 2023.

Read SEC document
April 03, 2023 Filed Apr 5, 2023 23:32 UTC
Desai NeilDirector · Executive Chairman · 10% owner
SaleCommon Stock 9,583 $7.45 $71,355.02
Disclosure

SEC source: 0001209191-23-023483 · doc4.xml · nonDerivative · entry 1

Desai Neil · CIK 0001878692 · Director · Executive Chairman · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 1,905,960

F1 · kind: The sales reported were effected pursuant to a Rule 10b5-1 trading plan originally adopted on September 20, 2021, as replaced on December 1, 2022, by the Reporting Person.

F2 · price: Represents the weighted average share price of an aggregate total of 9,583 shares sold in the price range of $7.29 to $7.59 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

F3 · ownership.nature: Shares held by Neil Prafulla Desai, Trustee of the Anishka Family Trust (the "Family Trust"). The Reporting Person is trustee of the Family Trust.

Read SEC document
March 27, 2023 Filed Mar 29, 2023 20:20 UTC GrantStock Option (right to buy) · Derivative 59,206 $0.00 Strike: $7.25 $0.00
Disclosure

SEC source: 0001209191-23-021531 · doc4.xml · derivative · entry 1

Hirmand Mohammad · CIK 0001654482 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 59,206

Underlying: Common Stock · 59,206 shares

Expires 2033-03-27

F1 · derivative.exercise_date: Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, one thirty-sixth (1/36th) of the shares subject to the option shall vest on a monthly basis following the grant date on the same day of the month as the grant date (and if there is no corresponding day, on the last day of the month) such that all shares subject to option shall be fully vested on the three year anniversary of the grant date. The grant date is March 27, 2023.

Read SEC document
March 01, 2023 Filed Mar 2, 2023 16:10 UTC
ITRI LORETTTA MChief Medical Officer
GrantStock option (right to buy) · Derivative 102,350 $0.00 Strike: $10.93 $0.00
Disclosure

SEC source: 0001209191-23-014615 · doc4.xml · derivative · entry 1

ITRI LORETTTA M · CIK 0001137918 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 102,350

Underlying: Common Stock · 102,350 shares

Expires 2033-03-01

F1 · derivative.exercise_date: Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, twenty five percent (25%) of the shares subject to the option shall vest on the one year anniversary of the Vesting Commencement Date, and one forty-eighth (1/48th) of the total shares subject to the option shall vest each month thereafter on the same day as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month) such that all shares of common stock subject to the option shall be fully vested on the four year anniversary of the Vesting Commencement Date. "Vesting Commencement Date" shall mean March 1, 2023.

Read SEC document
March 01, 2023 Filed Mar 2, 2023 21:05 UTC
Delaney BrendanDirector · See remarks
GrantStock option (right to buy) · Derivative 235,000 $0.00 Strike: $10.93 $0.00
Disclosure

SEC source: 0001209191-23-014589 · doc4.xml · derivative · entry 1

Delaney Brendan · CIK 0001722585 · Director · See remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 235,000

Underlying: Common Stock · 235,000 shares

Expires 2033-03-01

F1 · derivative.exercise_date: Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, twenty five percent (25%) of the shares subject to the option shall vest on the one year anniversary of the Vesting Commencement Date, and one forty-eighth (1/48th) of the total shares subject to the option shall vest each month thereafter on the same day as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month) such that all shares of common stock subject to the option shall be fully vested on the four year anniversary of the Vesting Commencement Date. "Vesting Commencement Date" shall mean March 1, 2023.

Read SEC document
March 01, 2023 Filed Mar 2, 2023 21:08 UTC
Giacobello Scott M.Chief Financial Officer
GrantStock option (right to buy) · Derivative 90,000 $0.00 Strike: $10.93 $0.00
Disclosure

SEC source: 0001209191-23-014603 · doc4.xml · derivative · entry 1

Giacobello Scott M. · CIK 0001754154 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 90,000

Underlying: Common Stock · 90,000 shares

Expires 2033-03-01

F1 · derivative.exercise_date: Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, twenty five percent (25%) of the shares subject to the option shall vest on the one year anniversary of the Vesting Commencement Date, and one forty-eighth (1/48th) of the total shares subject to the option shall vest each month thereafter on the same day as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month) such that all shares of common stock subject to the option shall be fully vested on the four year anniversary of the Vesting Commencement Date. "Vesting Commencement Date" shall mean March 1, 2023.

Read SEC document
January 03, 2023 Filed Jan 4, 2023 21:05 UTC
Desai NeilDirector · Executive Chairman · 10% owner
GrantStock option (right to buy) · Derivative 150,000 $0.00 Strike: $12.31 $0.00
Disclosure

SEC source: 0001209191-23-000843 · doc4.xml · derivative · entry 1

Desai Neil · CIK 0001878692 · Director · Executive Chairman · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 150,000

Underlying: Common Stock · 150,000 shares

Expires 2033-01-03

F1 · derivative.exercise_date: Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, twenty five percent (25%) of the shares subject to the option shall vest on the one year anniversary of the Vesting Commencement Date, and one forty-eighth (1/48th) of the total shares subject to the option shall vest each month thereafter on the same day as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month) such that all shares of common stock subject to the option shall be fully vested on the four year anniversary of the Vesting Commencement Date. "Vesting Commencement Date" shall mean January 1, 2023.

Read SEC document
January 03, 2023 Filed Jan 4, 2023 21:08 UTC
Delaney BrendanDirector · See remarks
GrantStock option (right to buy) · Derivative 150,000 $0.00 Strike: $12.31 $0.00
Disclosure

SEC source: 0001209191-23-000857 · doc4.xml · derivative · entry 1

Delaney Brendan · CIK 0001722585 · Director · See remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 150,000

Underlying: Common Stock · 150,000 shares

Expires 2033-01-03

F1 · derivative.exercise_date: Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, twenty five percent (25%) of the shares subject to the option shall vest on the one year anniversary of the Vesting Commencement Date, and one forty-eighth (1/48th) of the total shares subject to the option shall vest each month thereafter on the same day as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month) such that all shares of common stock subject to the option shall be fully vested on the four year anniversary of the Vesting Commencement Date. "Vesting Commencement Date" shall mean January 1, 2023.

Read SEC document
September 26, 2022 Filed Sep 27, 2022 23:18 UTC
Delaney BrendanChief Operating Officer
GrantCommon Stock 20,000 $12.50 $250,000.00
Disclosure

SEC source: 0001209191-22-051389 · doc4.xml · nonDerivative · entry 1

Delaney Brendan · CIK 0001722585 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,000

Read SEC document
September 26, 2022 Filed Sep 27, 2022 23:21 UTC GrantCommon Stock 240,000 $12.50 $3,000,000.00
Disclosure

SEC source: 0001209191-22-051391 · doc4.xml · nonDerivative · entry 1

Castelein Caley · CIK 0001355758 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 499,998

F1 · ownership.nature: Shares held by KVP Capital, LP. The Reporting Person is the Managing Director of KVP Capital. The Reporting Person disclaims beneficial ownership of shares held by KVP Capital, except to the extent of their pecuniary interest therein.

Read SEC document
September 26, 2022 Filed Sep 27, 2022 23:20 UTC
Dalal AnupamDirector
GrantCommon Stock 320,000 $12.50 $4,000,000.00
Disclosure

SEC source: 0001209191-22-051390 · doc4.xml · nonDerivative · entry 1

Dalal Anupam · CIK 0001602474 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 1,849,402

F1 · ownership.nature: Consists of (i) 1,572,698 shares held by Acuta Capital Fund, LP ("Acuta Capital") and (ii) 276,704 shares held by Acuta Opportunity Fund, LP. ("Acuta Opportunity Fund"). Acuta Capital Partners, LLC ("Acuta Partners") is the general partner of each of Acuta Capital and Acuta Opportunity Fund. The Reporting Person is the Chief Investment Officer and Managing Member of Acuta Partners. The Reporting Person has voting and investment authority over all of the shares held by each of Acuta Capital and Acuta Opportunity Fund. Each of Acuta Partners and the Reporting Person disclaim beneficial ownership of the shares of common stock held by each of Acuta Capital and Acuta Opportunity Fund except to the extent of their pecuniary interest therein.

Read SEC document
September 26, 2022 Filed Sep 27, 2022 23:17 UTC
Giacobello Scott M.Chief Financial Officer
GrantCommon Stock 20,000 $12.50 $250,000.00
Disclosure

SEC source: 0001209191-22-051388 · doc4.xml · nonDerivative · entry 1

Giacobello Scott M. · CIK 0001754154 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,000

Read SEC document
September 22, 2022 Filed Sep 26, 2022 21:46 UTC
Aghazadeh BehzadDirector · 10% owner · See Remarks
Avoro Capital Advisors LLCDirector · 10% owner · See Remarks
Avoro Ventures LLCDirector · 10% owner · See Remarks
GrantCommon Stock, $0.0001 par value per share ("Common Stock") 1,260,000 $12.50 $15,750,000.00
Disclosure

SEC source: 0000902664-22-004356 · ownership.xml · nonDerivative · entry 1

Aghazadeh Behzad · CIK 0001701815 · Director · 10% owner · See Remarks

Avoro Capital Advisors LLC · CIK 0001633313 · Director · 10% owner · See Remarks

Avoro Ventures LLC · CIK 0001879253 · Director · 10% owner · See Remarks

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnotes

Disclosed balance after: 3,471,752

F1 · kind: The securities reported herein were acquired on behalf of accounts managed by Avoro Capital Advisors and Avoro Ventures (as defined below) directly from the Issuer in a private placement.

F2 · ownership.nature: This Form 4 is filed by Avoro Capital Advisors LLC, a Delaware limited liability company ("Avoro Capital Advisors"), Avoro Ventures LLC, a Delaware limited liability company ("Avoro Ventures") and Behzad Aghazadeh ("Dr. Aghazadeh", and together with Avoro Capital Advisors and Avoro Ventures, the "Reporting Persons"). Dr. Aghazadeh serves as the portfolio manager and controlling person of Avoro Capital Advisors and Avoro Ventures.

F3 · ownership.nature: The filing of this statement shall not be deemed an admission that any Reporting Person is the beneficial owner of the securities reported herein for purposes of Section 16 of the Securities Act of 1934, as amended, or otherwise. Each of the Reporting Persons expressly disclaims beneficial ownership of the securities reported herein except to the extent of its or his pecuniary interest therein.

Read SEC document
June 15, 2022 Filed Jun 17, 2022 20:21 UTC
Aghazadeh BehzadDirector · 10% owner · See remarks
Avoro Capital Advisors LLCDirector · 10% owner · See remarks
Avoro Ventures LLCDirector · 10% owner · See remarks
GrantStock Option (right to buy) · Derivative 18,573 $0.00 Strike: $13.46 $0.00
Disclosure

SEC source: 0001209191-22-037859 · doc4.xml · derivative · entry 1

Aghazadeh Behzad · CIK 0001701815 · Director · 10% owner · See remarks

Avoro Capital Advisors LLC · CIK 0001633313 · Director · 10% owner · See remarks

Avoro Ventures LLC · CIK 0001879253 · Director · 10% owner · See remarks

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,573

Underlying: Common Stock · 18,573 shares

Expires 2032-06-15

F1 · derivative.exercise_date: Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through such applicable date, one hundred percent (100%) of the shares subject to the option shall vest on the earlier of the (i) the one (1) year anniversary of the Date of Grant or (ii) the day immediately prior to the next annual meeting of stockholders following the Date of Grant. "Date of Grant" shall mean June 15, 2022.

F2 · ownership.direct: This Form 4 is filed by Avoro Capital Advisors LLC, a Delaware limited liability company ("Avoro Capital Advisors"), Avoro Ventures LLC, a Delaware limited liability company ("Avoro Ventures") and Behzad Aghazadeh ("Dr. Aghazadeh", and together with Avoro Capital Advisors and Avoro Ventures, the "Reporting Persons"). Dr. Aghazadeh serves as the portfolio manager and controlling person of Avoro Capital Advisors and Avoro Ventures LLC.

F3 · ownership.direct: The filing of this statement shall not be deemed an admission that any Reporting Person is the beneficial owner of the securities reported herein for purposes of Section 16 of the Securities Act of 1934, as amended, or otherwise. Each of the Reporting Persons expressly disclaims beneficial ownership of the securities reported herein except to the extent of its or his pecuniary interest therein.

Read SEC document
June 15, 2022 Filed Jun 17, 2022 20:28 UTC
Reeve EmmaDirector
GrantStock Option (right to buy) · Derivative 18,573 $0.00 Strike: $13.46 $0.00
Disclosure

SEC source: 0001209191-22-037893 · doc4.xml · derivative · entry 1

Reeve Emma · CIK 0001680329 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,573

Underlying: Common Stock · 18,573 shares

Expires 2032-06-15

F1 · derivative.exercise_date: Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through such applicable date, one hundred percent (100%) of the shares subject to the option shall vest on the earlier of the (i) the one (1) year anniversary of the Date of Grant or (ii) the day immediately prior to the next annual meeting of stockholders following the Date of Grant. "Date of Grant" shall mean June 15, 2022.

Read SEC document
June 15, 2022 Filed Jun 17, 2022 20:26 UTC GrantStock Option (right to buy) · Derivative 18,573 $0.00 Strike: $13.46 $0.00
Disclosure

SEC source: 0001209191-22-037883 · doc4.xml · derivative · entry 1

Hehenberger Karin M. · CIK 0001548029 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,573

Underlying: Common Stock · 18,573 shares

Expires 2032-06-15

F1 · derivative.exercise_date: Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through such applicable date, one hundred percent (100%) of the shares subject to the option shall vest on the earlier of the (i) the one (1) year anniversary of the Date of Grant or (ii) the day immediately prior to the next annual meeting of stockholders following the Date of Grant. "Date of Grant" shall mean June 15, 2022.

Read SEC document
June 15, 2022 Filed Jun 17, 2022 20:27 UTC GrantStock Option (right to buy) · Derivative 18,573 $0.00 Strike: $13.46 $0.00
Disclosure

SEC source: 0001209191-22-037888 · doc4.xml · derivative · entry 1

Maroun Richard E · CIK 0001364590 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,573

Underlying: Common Stock · 18,573 shares

Expires 2032-06-15

F1 · derivative.exercise_date: Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through such applicable date, one hundred percent (100%) of the shares subject to the option shall vest on the earlier of the (i) the one (1) year anniversary of the Date of Grant or (ii) the day immediately prior to the next annual meeting of stockholders following the Date of Grant. "Date of Grant" shall mean June 15, 2022.

Read SEC document
June 15, 2022 Filed Jun 17, 2022 20:24 UTC
Dalal AnupamDirector
GrantStock Option (right to buy) · Derivative 18,573 $0.00 Strike: $13.46 $0.00
Disclosure

SEC source: 0001209191-22-037874 · doc4.xml · derivative · entry 1

Dalal Anupam · CIK 0001602474 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,573

Underlying: Common Stock · 18,573 shares

Expires 2032-06-15

F1 · derivative.exercise_date: Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through such applicable date, one hundred percent (100%) of the shares subject to the option shall vest on the earlier of the (i) the one (1) year anniversary of the Date of Grant or (ii) the day immediately prior to the next annual meeting of stockholders following the Date of Grant. "Date of Grant" shall mean June 15, 2022.

Read SEC document
June 15, 2022 Filed Jun 17, 2022 20:22 UTC GrantStock Option (right to buy) · Derivative 18,573 $0.00 Strike: $13.46 $0.00
Disclosure

SEC source: 0001209191-22-037866 · doc4.xml · derivative · entry 1

Castelein Caley · CIK 0001355758 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,573

Underlying: Common Stock · 18,573 shares

Expires 2032-06-15

F1 · derivative.exercise_date: Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through such applicable date, one hundred percent (100%) of the shares subject to the option shall vest on the earlier of the (i) the one (1) year anniversary of the Date of Grant or (ii) the day immediately prior to the next annual meeting of stockholders following the Date of Grant. "Date of Grant" shall mean June 15, 2022.

Read SEC document
April 01, 2022 Filed Apr 6, 2022 00:14 UTC
Desai NeilDirector · See Remarks · 10% owner
GrantStock option (right to buy) · Derivative 153,300 $0.00 Strike: $17.24 $0.00
Disclosure

SEC source: 0001209191-22-023349 · doc4.xml · derivative · entry 1

Desai Neil · CIK 0001878692 · Director · See Remarks · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 153,300

Underlying: Common Stock · 153,300 shares

Expires 2032-04-01

F1 · derivative.exercise_date: Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, twenty five percent (25%) of the shares subject to the option shall vest on the one year anniversary of the Vesting Commencement Date, and one forty-eighth (1/48th) of the total shares subject to the option shall vest each month thereafter on the same day as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month) such that all shares of common stock subject to the option shall be fully vested on the four year anniversary of the Vesting Commencement Date. "Vesting Commencement Date" shall mean April 1, 2022.

Read SEC document
April 01, 2022 Filed Apr 5, 2022 20:18 UTC
ITRI LORETTTA MChief Medical Officer
GrantStock option (right to buy) · Derivative 67,300 $0.00 Strike: $17.24 $0.00
Disclosure

SEC source: 0001209191-22-023351 · doc4.xml · derivative · entry 1

ITRI LORETTTA M · CIK 0001137918 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 67,300

Underlying: Common Stock · 67,300 shares

Expires 2032-04-01

F1 · derivative.exercise_date: Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, twenty five percent (25%) of the shares subject to the option shall vest on the one year anniversary of the Vesting Commencement Date, and one forty-eighth (1/48th) of the total shares subject to the option shall vest each month thereafter on the same day as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month) such that all shares of common stock subject to the option shall be fully vested on the four year anniversary of the Vesting Commencement Date. "Vesting Commencement Date" shall mean April 1, 2022.

Read SEC document
April 01, 2022 Filed Apr 6, 2022 00:19 UTC
Delaney BrendanChief Operating Officer
GrantStock option (right to buy) · Derivative 61,000 $0.00 Strike: $17.24 $0.00
Disclosure

SEC source: 0001209191-22-023352 · doc4.xml · derivative · entry 1

Delaney Brendan · CIK 0001722585 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 61,000

Underlying: Common Stock · 61,000 shares

Expires 2032-04-01

F1 · derivative.exercise_date: Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, twenty five percent (25%) of the shares subject to the option shall vest on the one year anniversary of the Vesting Commencement Date, and one forty-eighth (1/48th) of the total shares subject to the option shall vest each month thereafter on the same day as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month) such that all shares of common stock subject to the option shall be fully vested on the four year anniversary of the Vesting Commencement Date. "Vesting Commencement Date" shall mean April 1, 2022.

Read SEC document
April 01, 2022 Filed Apr 6, 2022 00:17 UTC
Giacobello Scott M.Chief Financial Officer
GrantStock option (right to buy) · Derivative 46,400 $0.00 Strike: $17.24 $0.00
Disclosure

SEC source: 0001209191-22-023350 · doc4.xml · derivative · entry 1

Giacobello Scott M. · CIK 0001754154 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 46,400

Underlying: Common Stock · 46,400 shares

Expires 2032-04-01

F1 · derivative.exercise_date: Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, twenty five percent (25%) of the shares subject to the option shall vest on the one year anniversary of the Vesting Commencement Date, and one forty-eighth (1/48th) of the total shares subject to the option shall vest each month thereafter on the same day as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month) such that all shares of common stock subject to the option shall be fully vested on the four year anniversary of the Vesting Commencement Date. "Vesting Commencement Date" shall mean April 1, 2022.

Read SEC document
March 18, 2022 Filed Mar 22, 2022 21:34 UTC
Desai NeilDirector · See Remarks · 10% owner
SaleCommon Stock 3,550 $20.07 $71,233.59
Disclosure

SEC source: 0001209191-22-020582 · doc4.xml · nonDerivative · entry 1

Desai Neil · CIK 0001878692 · Director · See Remarks · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 1,915,543

F1 · kind: The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted on September 20, 2021 by the Reporting Person.

F2 · price: Represents the weighted average share price of an aggregate total of 3,550 shares sold in the price range of $20.00 to $20.09 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

F3 · ownership.nature: Shares held by Neil Prafulla Desai, Trustee of the Anishka Family Trust (the "Family Trust"). The Reporting Person is trustee of the Family Trust.

Read SEC document
October 21, 2021 Filed Oct 25, 2021 19:27 UTC
ITRI LORETTTA MChief Medical Officer
GrantStock option (right to buy) · Derivative 185,000 $0.00 Strike: $26.85 $0.00
Disclosure

SEC source: 0000899243-21-041483 · doc4.xml · derivative · entry 1

ITRI LORETTTA M · CIK 0001137918 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 185,000

Underlying: Common Stock · 185,000 shares

Expires 2031-10-21

F1 · derivative.exercise_date: Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, twenty five percent (25%) of the shares subject to the option shall vest on the one year anniversary of the Vesting Commencement Date, and one forty-eighth (1/48th) of the total shares subject to the option shall vest each month thereafter on the same day as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month) such that all shares of common stock subject to the option shall be fully vested on the four year anniversary of the Vesting Commencement Date. "Vesting Commencement Date" shall mean October 21, 2021.

Read SEC document
September 20, 2021 Filed Sep 22, 2021 20:13 UTC
Delaney BrendanChief Operating Officer
GrantStock option (right to buy) · Derivative 260,000 $0.00 Strike: $29.09 $0.00
Disclosure

SEC source: 0000899243-21-037065 · doc4.xml · derivative · entry 1

Delaney Brendan · CIK 0001722585 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 260,000

Underlying: Common Stock · 260,000 shares

Expires 2031-09-20

F1 · derivative.exercise_date: Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, twenty five percent (25%) of the shares subject to the option shall vest on the one year anniversary of the Vesting Commencement Date, and one forty-eighth (1/48th) of the total shares subject to the option shall vest each month thereafter on the same day as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month) such that all shares of common stock subject to the option shall be fully vested on the four year anniversary of the Vesting Commencement Date. "Vesting Commencement Date" shall mean September 20, 2021.

Read SEC document
September 08, 2021 Filed Sep 10, 2021 21:05 UTC
Desai NeilDirector · See Remarks · 10% owner
GrantStock option (right to buy) · Derivative 125,000 $0.00 Strike: $27.67 $0.00
Disclosure

SEC source: 0000899243-21-035568 · doc4.xml · derivative · entry 1

Desai Neil · CIK 0001878692 · Director · See Remarks · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 125,000

Underlying: Common Stock · 125,000 shares

Expires 2031-09-08

F1 · derivative.exercise_date: Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, twenty five percent (25%) of the shares subject to the option shall vest on the one year anniversary of the Vesting Commencement Date, and one thirty-sixth (1/36th) of the remaining shares subject to the option shall vest each month thereafter on the same day as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month) such that all shares of common stock subject to the option shall be fully vested on the four year anniversary of the Vesting Commencement Date. "Vesting Commencement Date" shall mean September 8, 2021.

Read SEC document
September 08, 2021 Filed Sep 10, 2021 20:47 UTC
Reeve EmmaDirector
GrantStock option (right to buy) · Derivative 16,486 $0.00 Strike: $27.67 $0.00
Disclosure

SEC source: 0000899243-21-035558 · doc4.xml · derivative · entry 1

Reeve Emma · CIK 0001680329 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,486

Underlying: Common Stock · 16,486 shares

Expires 2031-09-08

F1 · derivative.exercise_date: Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, the Initial Award is scheduled to vest as to one thirty-sixth (1/36th) of the shares of common stock subject to the Initial Award on a monthly basis following the grant date on the same day of the month as the grant date (and if there is no corresponding day, on the last day of the month) such that all shares of common stock subject to the Initial Award shall be fully vested on the three year anniversary of the grant date. The grant date is September 8, 2021.

Read SEC document
August 27, 2021 Filed Aug 30, 2021 23:39 UTC
Aghazadeh BehzadDirector · 10% owner · See Remarks
Avoro Capital Advisors LLCDirector · See Remarks
GrantStock option (right to buy) · Derivative 17,549 $0.00 Strike: $26.00 $0.00
Disclosure

SEC source: 0000902664-21-004071 · ownership.xml · derivative · entry 2

Aghazadeh Behzad · CIK 0001701815 · Director · 10% owner · See Remarks

Avoro Capital Advisors LLC · CIK 0001633313 · Director · See Remarks

Avoro Ventures LLC · CIK 0001879253 · See Remarks

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,549

Underlying: Common Stock · 17,549 shares

Expires 2031-08-27

F4 · derivative.exercise_date: In connection with the closing of the Merger, as approved by the stockholders of the Issuer on August 17, 2021, the Board granted on August 26, 2021 to the Reporting Person an Initial Award (as defined in the Issuer's Outside Director Compensation Policy and in accordance with the Issuer's 2021 Equity Incentive Plan (the "Plan")). Subject to the Reporting Person continuing to be a Service Provider (as defined in the Plan) through each applicable date, the Initial Award is scheduled to vest as to one thirty-sixth (1/36th) of the shares of common stock subject to the Initial Award on a monthly basis following the grant date on the same day of the month as the grant date (and if there is no corresponding day, on the last day of the month). The grant date is August 27, 2021.

F1 · ownership.direct: This Form 4 is filed by Avoro Capital Advisors LLC, a Delaware limited liability company ("Avoro Capital Advisors"), Avoro Ventures LLC, a Delaware limited liability company ("Avoro Ventures") and Behzad Aghazadeh ("Dr. Aghazadeh", and together with Avoro Capital Advisors and Avoro Ventures, the "Reporting Persons"). Dr. Aghazadeh serves as the portfolio manager and controlling person of Avoro Capital Advisors and Avoro Ventures LLC.

F2 · ownership.direct: The filing of this statement shall not be deemed an admission that any Reporting Person is the beneficial owner of the securities reported herein for purposes of Section 16 of the Securities Act of 1934, as amended, or otherwise. Each of the Reporting Persons expressly disclaims beneficial ownership of the securities reported herein except to the extent of its or his pecuniary interest therein.

F4 · ownership.direct: In connection with the closing of the Merger, as approved by the stockholders of the Issuer on August 17, 2021, the Board granted on August 26, 2021 to the Reporting Person an Initial Award (as defined in the Issuer's Outside Director Compensation Policy and in accordance with the Issuer's 2021 Equity Incentive Plan (the "Plan")). Subject to the Reporting Person continuing to be a Service Provider (as defined in the Plan) through each applicable date, the Initial Award is scheduled to vest as to one thirty-sixth (1/36th) of the shares of common stock subject to the Initial Award on a monthly basis following the grant date on the same day of the month as the grant date (and if there is no corresponding day, on the last day of the month). The grant date is August 27, 2021.

Read SEC document
August 27, 2021 Filed Aug 31, 2021 01:11 UTC GrantStock option (right to buy) · Derivative 17,549 $0.00 Strike: $26.00 $0.00
Disclosure

SEC source: 0000899243-21-034553 · doc4.xml · derivative · entry 3

Castelein Caley · CIK 0001355758 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,549

Underlying: Common Stock · 17,549 shares

Expires 2031-08-27

F3 · derivative.exercise_date: In connection with the closing of the merger by and between Aerpio Pharmaceuticals, Inc. and Aadi Bioscience, Inc., as approved by the stockholders of the Issuer on August 17, 2021, the Board granted on August 26, 2021 to the Reporting Person an Initial Award (as defined in the Issuer's Outside Director Compensation Policy and in accordance with the Issuer's 2021 Equity Incentive Plan (the "Plan")). Subject to the Reporting Person continuing to be a Service Provider (as defined in the Plan) through each applicable date, the Initial Award is scheduled to vest as to one thirty-sixth (1/36th) of the shares of common stock subject to the Initial Award on a monthly basis following the grant date on the same day of the month as the grant date (and if there is no corresponding day, on the last day of the month). The grant date is August 27, 2021.

Read SEC document
August 27, 2021 Filed Aug 31, 2021 00:39 UTC
Dalal AnupamDirector
GrantStock option (right to buy) · Derivative 17,549 $0.00 Strike: $26.00 $0.00
Disclosure

SEC source: 0000899243-21-034546 · doc4.xml · derivative · entry 3

Dalal Anupam · CIK 0001602474 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,549

Underlying: Common Stock · 17,549 shares

Expires 2031-08-27

F2 · derivative.exercise_date: In connection with the closing of the merger by and between Aerpio Pharmaceuticals, Inc. and Aadi Bioscience, Inc., as approved by the stockholders of the Issuer on August 17, 2021, the Board granted on August 26, 2021 to the Reporting Person an Initial Award (as defined in the Issuer's Outside Director Compensation Policy and in accordance with the Issuer's 2021 Equity Incentive Plan (the "Plan")). Subject to the Reporting Person continuing to be a Service Provider (as defined in the Plan) through each applicable date, the Initial Award is scheduled to vest as to one thirty-sixth (1/36th) of the shares of common stock subject to the Initial Award on a monthly basis following the grant date on the same day of the month as the grant date (and if there is no corresponding day, on the last day of the month). The grant date is August 27, 2021.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.